| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Extend Fertility is the first service in the U.S. focused exclusively on women who want to proactively preserve their fertility options.
Biodesix Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Biodesix Inc is based in Broomfield, CO. You can find more information on Biodesix Inc at www.biodesix.com
Paramus Surgical Ctr is a Paramus, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Med-X Global is an LLC formed in the State of New Jersey. We operate as international revenue cycle consultants, third-party medical claims administrators and payment collectors adjudicating emergency medical claims for highly accredited foreign hospitals. Med-X also serves the ancillary emergency provider community in the foreign marketplace to include air and ground ambulance entities as well as premier urgent care centers and physician administered emergency sites. The majority of Med-X`s hospital clients operate clinically sophisticated facilities accredited by the General Heath Council (CSG) while still others are accredited by the Joint Commission International (JCI) reflecting a standard of care that typically meets or even exceeds the U.S. benchmark for quality providers.